Thus, it was concluded that esomeprazole could reduce serum levels of IL-β and TNF-α cytokines released from macrophages by reducing macrophage activation in rats with acute pancreatitis, showing anti-inflammatory activity and reducing the destructive effects of acute pancreatitis. Here, TNF is linked to acute pancreatitis.